Rezultaty - Jee‐Fu Huang
- Rezultaty 1 - 20 Rezultaty od 32
- Idź do następnej strony
-
1
-
2
Efficacy of TAS-120, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in cholangiocarcinoma patients with FGFR pathway alterations who were previously treated wi... od Funda Meric‐Bernstam, Hendrik-Tobias Arkenau, Ben Tran, Ratislav Bahleda, Robin Kate Kelley, Cinta Hierro, Daniel H. Ahn, Andrew X. Zhu, Milind Javle, Robert Winkler, Huan He, Jee‐Fu Huang, Lipika Goyal
Wydane 2018Artigo -
3
Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1386‐patient study from Taiwan od Jee‐Fu Huang, Ming‐Lung Yu, C. Lee, Chia‐Yen Dai, Nan Hou, M.-Y. Hsieh, John Wang, Sheng‐Nan Lu, I‐Shyan Sheen, Shi‐Ming Lin, Wan‐Long Chuang, Yun‐Fan Liaw
Wydane 2007Artigo -
4
Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy od Chih‐Wen Lin, Yaw-Sen Chen, Chih-Che Lin, Yun‐Ju Chen, Gin‐Ho Lo, Po‐Huang Lee, Po-Lin Kuo, Chia-Yen Dai, Jee‐Fu Huang, Wang-Long Chung, Ming‐Lung Yu
Wydane 2015Artigo -
5
-
6
Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma od Yu‐Han Huang, Chi Kuen Chan, Hye Won Lee, Claire Huang, Yen‐Ju Chen, Po-Chun Liu, Sheng‐Nan Lu, Wan‐Long Chuang, Jee‐Fu Huang, Ming‐Lung Yu, Jill Koshiol, Mei‐Hsuan Lee
Wydane 2022Artigo -
7
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C od Ming‐Lung Yu, CY Dai, Jee‐Fu Huang, Nan Hou, L.-P. Lee, Meng‐Hsuan Hsieh, C.-F. Chiu, Lin Zhong, Szu‐Chia Chen, Meng‐Hsuan Hsieh, Liping Wang, Wen‐Yu Chang, Wan‐Long Chuang
Wydane 2006Artigo -
8
Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment od Ming‐Lung Yu, Chung‐Feng Huang, Ming‐Lun Yeh, Pei‐Chien Tsai, Ching‐I Huang, Meng‐Hsuan Hsieh, Ming‐Yen Hsieh, Zu‐Yau Lin, Shinn‐Cherng Chen, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang
Wydane 2016Artigo -
9
Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis od Jee‐Fu Huang, Pei‐Chien Tsai, Ming‐Lun Yeh, Chung‐Feng Huang, Ching‐I Huang, Meng‐Hsuan Hsieh, Chia‐Yen Dai, Jeng‐Fu Yang, Shinn‐Chern Chen, Ming‐Lung Yu, Wan‐Long Chuang, Wen‐Yu Chang
Wydane 2019Artigo -
10
Efficacy and Safety of Pegylated Interferon Combined with Ribavirin for the Treatment of Older Patients with Chronic Hepatitis C od Chung‐Feng Huang, Jeng‐Fu Yang, Chia‐Yen Dai, Jee‐Fu Huang, Nai‐Jen Hou, Ming‐Yen Hsieh, Zu‐Yau Lin, Shinn‐Cherng Chen, Ming‐Yuh Hsieh, Liang‐Yen Wang, Wen‐Yu Chang, Wan‐Long Chuang, Ming‐Lung Yu
Wydane 2010Artigo -
11
Hepatitis C Virus Infection among Injection Drug Users with and without Human Immunodeficiency Virus Co-Infection od Meng‐Hsuan Hsieh, Jih‐Jin Tsai, Ming‐Yen Hsieh, Chung‐Feng Huang, Ming‐Lun Yeh, Jeng‐Fu Yang, Ko Chang, Wei‐Ru Lin, Chun‐Yu Lin, Tun‐Chieh Chen, Jee‐Fu Huang, Chia‐Yen Dai, Ming‐Lung Yu, Wan‐Long Chuang
Wydane 2014Artigo -
12
Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial od Ming‐Lung Yu, Chia‐Yen Dai, Jee‐Fu Huang, Chang‐Fu Chiu, Yi‐Hsin Yang, Nai‐Jen Hou, Li‐Po Lee, Ming‐Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Ming‐Yuh Hsieh, Liang‐Yen Wang, Wen‐Yu Chang, Wan‐Long Chuang
Wydane 2008Artigo -
13
Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients od Ming‐Lung Yu, Chung‐Feng Huang, Jee‐Fu Huang, Ning‐Chia Chang, Jeng‐Fu Yang, Zu‐Yau Lin, Shinn‐Cherng Chen, Ming‐Yuh Hsieh, Liang‐Yen Wang, Wen‐Yu Chang, Yining Li, Mei-Shin Wu, Chia‐Yen Dai, Suh‐Hang Hank Juo, Wan‐Long Chuang
Wydane 2010Artigo -
14
Scaling up the in-hospital hepatitis C virus care cascade in Taiwan od Chung‐Feng Huang, Pey‐Fang Wu, Ming‐Lun Yeh, Ching-I Huang, Po‐Cheng Liang, Cheng‐Ting Hsu, Po‐Yao Hsu, Hung‐Yin Liu, Ying‐Chou Huang, Zu‐Yau Lin, Shinn‐Cherng Chen, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu
Wydane 2020Artigo -
15
Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients od Takanori Ito, Vy H. Nguyen, Taku Tanaka, Huiyul Park, Ming‐Lun Yeh, Miwa Kawanaka, Taeang Arai, Masanori Atsukawa, Eileen L. Yoon, Pei‐Chien Tsai, Hidenori Toyoda, Jee‐Fu Huang, Linda Henry, Dae Won Jun, Ming‐Lung Yu, Masatoshi Ishigami, Mindie H. Nguyen, Ramsey Cheung
Wydane 2022Artigo -
16
Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection od Ming‐Lun Yeh, Chung‐Feng Huang, Ching‐I Huang, Jacinta A. Holmes, Meng‐Hsuan Hsieh, Yi‐Shan Tsai, Po‐Cheng Liang, Pei‐Chien Tsai, Ming‐Yen Hsieh, Zu‐Yau Lin, Shinn‐Cherng Chen, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Raymond T. Chung, Ming‐Lung Yu
Wydane 2020Artigo -
17
Viral Hepatitis Infections in Southern Taiwan: A Multicenter Community‐based Study od Jeng‐Fu Yang, Chia‐I Lin, Jee‐Fu Huang, Chia‐Yen Dai, Wen‐Yi Lin, Chi‐Kung Ho, Ming‐Yen Hsieh, Li‐Po Lee, Nai‐Jen Ho, Zu‐Yau Lin, Shinn‐Cherng Chen, Ming‐Yuh Hsieh, Liang‐Yen Wang, Ming‐Lung Yu, Wan‐Long Chuang, Wen‐Yu Chang
Wydane 2010Artigo -
18
Huge Gap Between Clinical Efficacy and Community Effectiveness in the Treatment of Chronic Hepatitis C od Ming‐Lung Yu, Ming‐Lun Yeh, Pei‐Chien Tsai, Ching‐I Huang, Jee‐Fu Huang, Chung‐Feng Huang, Meng‐Hsuan Hsieh, Po‐Cheng Liang, Yi‐Hung Lin, Ming‐Yen Hsieh, Wen‐Yi Lin, Nai‐Jen Hou, Zu‐Yau Lin, Shinn‐Cherng Chen, Chia‐Yen Dai, Wan‐Long Chuang, Wen‐Yu Chang
Wydane 2015Artigo -
19
Long-term Risks of Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes od Yi‐Ting Chen, Tzu-I Chen, Tsai-Hsuan Yang, Szu‐Ching Yin, Sheng‐Nan Lu, Xia-Rong Liu, Yun-Zheng Gao, Chih-Jo Lin, Chia-Wei Huang, Jee‐Fu Huang, Ming-Lun Yeh, Chung‐Feng Huang, Chia‐Yen Dai, Wan‐Long Chuang, Hwai‐I Yang, Ming‐Lung Yu, Mei–Hsuan Lee
Wydane 2024Artigo -
20
Modelling NAFLD disease burden in four Asian regions—2019‐2030 od Chris Estes, Henry Lik‐Yuen Chan, Rong‐Nan Chien, Wan‐Long Chuang, James Fung, George Boon‐Bee Goh, Tsung H. Hu, Jee‐Fu Huang, Byoung Kuk Jang, Dae Won Jun, Jia‐Horng Kao, Jin‐Woo Lee, Han‐Chieh Lin, Kathryn Razavi‐Shearer, Wai‐Kay Seto, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, Homie Razavi
Wydane 2020Artigo
Narzędzie wyszukiwania:
Podobne hasła
Medicine
Internal medicine
Gastroenterology
Virus
Hepatitis C
Immunology
Hepatocellular carcinoma
Hepatitis C virus
Virology
Confidence interval
Disease
Cirrhosis
Physics
Chronic hepatitis
Fatty liver
Hepatitis B virus
Incidence (geometry)
Optics
Ribavirin
Liver disease
Cohort
HBsAg
Hepatitis B
Surgery
Antibody
Antiviral therapy
Environmental health
Fibrosis
Hazard ratio
Metabolic syndrome